Related Experiment Video
Updated: Jun 2, 2026
08:32
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Overcoming insulin resistance with ciliary neurotrophic factor
Tamara L Allen1, Vance B Matthews, Mark A Febbraio
1Cellular and Molecular Metabolism Laboratory, Baker IDI Heart and Diabetes Institute, 6492, St Kilda Road Central, Melbourne, 8008, VIC, Australia.
Handbook of Experimental Pharmacology
|April 13, 2011
Summary
Obesity and related conditions are rising globally. Ciliary neurotrophic factor (CNTF) shows promise for weight loss and improved insulin sensitivity, offering new therapeutic avenues.
Area of Science:
- Metabolic disorders
- Endocrinology
- Pharmacology
Background:
- Global rise in obesity and associated conditions like insulin resistance, dyslipidemia, and hypertension.
- Current interventions for obesity are often ineffective in halting disease progression.
- Previous anti-obesity drug candidates, such as leptin, have shown limited success.
Purpose of the Study:
- To evaluate the efficacy of ciliary neurotrophic factor (CNTF) as a potential therapeutic agent for obesity and related metabolic disorders.
- To explore CNTF's effectiveness in models of obesity and leptin resistance.
Main Methods:
- Investigated the effects of CNTF, a gp130 ligand, in preclinical models of obesity.
- Assessed CNTF's impact on weight and insulin sensitivity in both human and rodent subjects.
Main Results:
- CNTF demonstrated efficacy in promoting weight loss and enhancing insulin sensitivity.
- CNTF proved effective in models where leptin had previously failed.
Conclusions:
- CNTF is a promising therapeutic candidate for managing obesity and improving metabolic health.
- Further research into novel gp130 ligands could yield new drug therapies for obesity-related conditions.
Related Concept Videos
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...